Copper binding modulates the platination of human copper chaperone Atox1 by antitumor trans-platinum complexes
出版年份 2014 全文链接
标题
Copper binding modulates the platination of human copper chaperone Atox1 by antitumor trans-platinum complexes
作者
关键词
-
出版物
Metallomics
Volume 6, Issue 3, Pages 491-497
出版商
Royal Society of Chemistry (RSC)
发表日期
2014-01-07
DOI
10.1039/c3mt00338h
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Transporting platinum drugs from a copper chaperone to ATPase: the mechanistic implication of drug efflux mediated cisplatin resistance
- (2014) Dechen Xu et al. Inorganic Chemistry Frontiers
- Copper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxification
- (2013) Nataliya V. Dolgova et al. BIOCHEMICAL JOURNAL
- Copper binding promotes the interaction of cisplatin with human copper chaperone Atox1
- (2013) Zhaoyong Xi et al. CHEMICAL COMMUNICATIONS
- An Updated View of Cisplatin Transport
- (2013) Fabio Arnesano et al. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- Interaction of cisplatin and analogue Pt(en)Cl2 with the copper metallo-chaperone Atox1
- (2013) Chak Ming Sze et al. Metallomics
- Conserved residue modulates copper-binding properties through structural dynamics in human copper chaperone Atox1
- (2013) Zhaoyong Xi et al. Metallomics
- PtCl2(phen) disrupts the metal ions binding to amyloid-β peptide
- (2013) Guolin Ma et al. Metallomics
- Determinants for Simultaneous Binding of Copper and Platinum to Human Chaperone Atox1: Hitchhiking not Hijacking
- (2013) Maria E. Palm-Espling et al. PLoS One
- Interactions of anticancer Pt compounds with proteins: an overlooked topic in medicinal inorganic chemistry?
- (2012) Angela Casini et al. Chemical Science
- Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7BThis paper is one of a selection of papers published in a Special Issue entitled CSBMCB 53rd Annual Meeting — Membrane Proteins in Health and Disease, and has undergone the Journal’s usual peer review process.
- (2011) Oleg Y. Dmitriev Biochemistry and Cell Biology
- Distorted copper homeostasis with decreased sensitivity to cisplatin upon chaperone Atox1 deletion in Drosophila
- (2011) Haiqing Hua et al. BIOMETALS
- The anticancer drug cisplatin can cross-link the interdomain zinc site on human albumin
- (2011) Wenbing Hu et al. CHEMICAL COMMUNICATIONS
- Probing the Interaction of Cisplatin with the Human Copper Chaperone Atox1 by Solution and In-Cell NMR Spectroscopy
- (2011) Fabio Arnesano et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Cisplatin binds human copper chaperone Atox1 and promotes unfolding in vitro
- (2011) M. E. Palm et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
- (2010) S. B. Howell et al. MOLECULAR PHARMACOLOGY
- Methionine Can Favor DNA Platination bytrans-Coordinated Platinum Antitumor Drugs
- (2009) Chan Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The soluble metal-binding domain of the copper transporter ATP7B binds and detoxifies cisplatin
- (2009) Nataliya V. Dolgova et al. BIOCHEMICAL JOURNAL
- Structural Biology of Copper Trafficking
- (2009) Amie K. Boal et al. CHEMICAL REVIEWS
- Towards Antitumor Activetrans-Platinum Compounds
- (2009) Sheena M. Aris et al. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- Crystal Structures of Cisplatin Bound to a Human Copper Chaperone
- (2009) Amie K. Boal et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Effects of the loss of Atox1 on the cellular pharmacology of cisplatin
- (2008) Roohangiz Safaei et al. JOURNAL OF INORGANIC BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More